Why is Shukra Pharma. falling/rising?

As of 02-Sep, Shukra Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs. 27.27, reflecting a rise of 0.53 (1.98%). The stock has recently hit a new 52-week high and has been on a consecutive gain streak for the last 11 days, resulting in a remarkable 51.92% return during this period. Additionally, Shukra Pharmaceuticals has outperformed its sector by 2.05% today and is trading above all key moving averages, indicating strong momentum. The company also demonstrates a strong ability to service its debt with a low Debt to EBITDA ratio of 1.28 times and has shown healthy long-term growth with an annual operating profit increase of 62.04%. Over the past year, the stock has generated an impressive 315.19% return, consistently outperforming the BSE500 in each of the last three annual periods.
In the broader market context, Shukra Pharmaceuticals has significantly outperformed the benchmark Sensex, which has seen a decline of 0.78% over the past week while the stock itself has risen by 8.17%. This stark contrast highlights the stock's strong performance relative to the market. Furthermore, the stock's year-to-date return of 99.97% also surpasses the Sensex's modest gain of 2.58%, reinforcing the positive sentiment around Shukra Pharmaceuticals amidst a generally challenging market environment.